Altis Biosystems, which specializes in using human intestinal tissue cells to test novel drug therapies, has announced the recipient of its second Research Funding Initiative. Here are the details.
Read More
Venture capital and fundraising through new equity or debt is off to a strong start in August despite concerns about a possible recession, according to numerous SEC filings.
Read More
The Durham-based biotechnology business has announced a second funding initiative focused on speeding up research into complex diseases through its RepliGut Planar model. The RepliGut platform helps scientists develop safer and more effective drugs by using human intestinal tissue for in vitro testing.
Read More
Durham-based Altis Biosystems is offering a research award of up to $10,000 for a scientific team to use its proprietary drug-development technology in a research projec
Read More
Altis Biosystems has developed a unique platform for testing drugs for intestinal disease that can make drug discovery faster, cheaper, and safer, and reduces the need for animal testing.
Read More
Altis Biosystems, a Chapel Hill-based biotech research tools company, has raised just north of $3.1 million from a total of 42 investors.
Read More
Altis Biosystems and Innovate Biopharmaceuticals are among a handful of companies that have raised millions in funding to kick off the new decade. Read more here.
Read More
